PBLA · Categories · Form 4

PBLA - SEC Form 4 insider transactions

Panbela Therapeutics Inc. (PBLA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PBLA

• 571d
  SEC Form 4 filed by Large owner Nant Capital, Llc

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 618d
  SEC Form 4 filed by V.P. of Finance & CFO Horvath Susan

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 618d
  SEC Form 4 filed by President and CEO Simpson Jennifer K.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 943d
  Goldman Sachs Group Inc sold $51,741 worth of shares (72,874 units at $0.71) (SEC Form 4)

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1003d
  SEC Form 4: Jacob Jeffrey E. gifted 275 shares

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Simpson Jennifer K.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Horvath Susan

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Cullen Michael T.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Donovan Daniel

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Fratamico Arthur

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Jacob Jeffrey E.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Mathiesen Jeffrey S

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1172d
  SEC Form 4 filed by Schemel Donald Robert

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1228d
  SEC Form 4: Simpson Jennifer K. bought 4,444 shares, increasing direct ownership by 130% to 7,868 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1228d
  SEC Form 4: Horvath Susan bought 4,444 shares, increasing direct ownership by 33% to 17,880 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1346d
  SEC Form 4: Cullen Michael T. bought 165,000 shares

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1346d
  SEC Form 4: Schemel Donald Robert bought 200,000 shares

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1346d
  SEC Form 4: Jacob Jeffrey E. bought 33,000 shares, increasing direct ownership by 13% to 294,931 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1732d
  SEC Form 4 filed by Simpson Jennifer K.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1732d
  SEC Form 4 filed by Horvath Susan

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1828d
  SEC Form 4: Gagnon Suzanne gifted 8,142 units of Common Stock and received a gift of 3,284 units of Common Stock, increasing direct ownership by 8% to 46,284 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1843d
  SEC Form 4 filed by Panbela Therapeutics, Inc.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1843d
  SEC Form 4: Schemel Donald Robert was granted 4,316 units of Common Stock, increasing direct ownership by 5% to 96,619 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1843d
  SEC Form 4: MATHIESEN JEFFREY S was granted 4,316 units of Common Stock, increasing direct ownership by 73% to 10,191 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1843d
  SEC Form 4 filed by Panbela Therapeutics, Inc.

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1843d
  SEC Form 4: Cullen Michael T. was granted 4,316 units of Common Stock, increasing direct ownership by 2% to 216,811 units

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1899d
  SEC Form 4 filed by K. Jennifer Simpson

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1899d
  SEC Form 4 filed by Susan Horvath

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1899d
  SEC Form 4 filed by Suzanne Gagnon

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)
• 1899d
  SEC Form 4 filed by T. Michael Cullen

  4 - Panbela Therapeutics, Inc. (0001029125) (Issuer)

Other PBLA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends